- (01/2009) ALS TDI and Asklepios to Develop New Therapeutic Delivery Options for Treating Lou Gehrig's Disease
- (09/2006) Asklepios, GSK to Commercialize Gene Therapy Treatments
- (03/2006) First U.S. Trial of DMD Underway
- (05/2005) Asklepios Biopharmaceutical, Inc. and Bayer Healthcare, LLC Announce Collaboration on Gene Therapy for the Treatment of Hemophilia
- (01/2005) MTF, Asklepios Biopharmaceutical to collaborate on developing solutions to orthopedic tissue repair.
- (08/2004) AskBio awarded largest grant to a private company in Muscular Dystrophy Association history.
- (07/2004) AskBio announces upcoming launch of Phase 1 trial of BiostrophinTM for Duchenne Muscular Dystrophy.
- (05/2004) AskBio supported by the North Carolina Biotechnology Center, awarded with the Business Development Award Program supporting business-related activities critical to the commercialization of the company's technology.
- (04/2004) Phil Scuderi, Ph.D. the Director of Research for Bayer HealthCare, Biological Products Division, has agreed to join AskBio's Scientific Advisory Board.